Literature DB >> 11898939

Does PSA screening reduce prostate cancer mortality?

André N Vis1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11898939      PMCID: PMC99402     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  21 in total

1.  Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.

Authors:  P Carroll; C Coley; D McLeod; P Schellhammer; G Sweat; J Wasson; A Zietman; I Thompson
Journal:  Urology       Date:  2001-02       Impact factor: 2.649

2.  Why is the prostate cancer death rate declining in the United States?

Authors:  C J Mettlin; G P Murphy
Journal:  Cancer       Date:  1998-01-15       Impact factor: 6.860

3.  Cancer statistics, 2001.

Authors:  R T Greenlee; M B Hill-Harmon; T Murray; M Thun
Journal:  CA Cancer J Clin       Date:  2001 Jan-Feb       Impact factor: 508.702

4.  American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection.

Authors:  R A Smith; A C von Eschenbach; R Wender; B Levin; T Byers; D Rothenberger; D Brooks; W Creasman; C Cohen; C Runowicz; D Saslow; V Cokkinides; H Eyre
Journal:  CA Cancer J Clin       Date:  2001 Jan-Feb       Impact factor: 508.702

5.  Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria.

Authors:  G Bartsch; W Horninger; H Klocker; A Reissigl; W Oberaigner; D Schönitzer; G Severi; C Robertson; P Boyle
Journal:  Urology       Date:  2001-09       Impact factor: 2.649

Review 6.  Nutritional aspects of prostate cancer: a review.

Authors:  A J Blumenfeld; N Fleshner; B Casselman; J Trachtenberg
Journal:  Can J Urol       Date:  2000-02       Impact factor: 1.344

7.  PSA screening and prostate cancer mortality.

Authors:  Linda Perron; Lynne Moore; Isabelle Bairati; Paul-Marie Bernard; François Meyer
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

8.  Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.

Authors:  F Labrie; B Candas; A Dupont; L Cusan; J L Gomez; R E Suburu; P Diamond; J Lévesque; A Belanger
Journal:  Prostate       Date:  1999-02-01       Impact factor: 4.104

9.  The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry.

Authors:  R A Stephenson; C R Smart; G P Mineau; B C James; D T Janerich; R L Dibble
Journal:  Cancer       Date:  1996-04-01       Impact factor: 6.860

10.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer.

Authors:  P H Gann; C H Hennekens; M J Stampfer
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272

View more
  2 in total

1.  Interpreting the Quebec prostate cancer study.

Authors:  Fernand Labrie; Bernard Candas
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

Review 2.  Recent developments in prostate cancer biomarker research: therapeutic implications.

Authors:  Sujitra Detchokul; Albert G Frauman
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.